Experimental therapy for deadly brain tumor stalls after single patient
Disease control
Terminated
This phase 2 study tests two experimental drugs, atengenal and astugenal, in people with diffuse intrinsic pontine glioma (DIPG), a rare and aggressive brain tumor. The trial aimed to enroll up to 100 participants across five age and treatment groups, but only 1 person joined bef…
Phase: PHASE2 • Sponsor: Burzynski Research Institute • Aim: Disease control
Last updated Jun 26, 2026 18:14 UTC